EUVIMEDEUVIMED entdecken
Crossref

Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant

Filip Ionescu, Jerel C David, Apoorva Ravichandran, David A Sallman, Kendra Sweet, Rami S Komrokji, Onyee Chan, Andrew Kuykendall, Eric Padron, Rawan Faramand, Nelli Bejanyan, Farhad Khimani und 6 weitere

Clinical Lymphoma Myeloma and Leukemia · 2024-06 · 24 (6) · 400-406

DOI: 10.1016/j.clml.2024.02.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2024-06. Verfasst von Filip Ionescu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Bridged Bicyclo Compounds, Heterocyclic, Leukemia, Myeloid, Acute, Sulfonamides. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Moffitt Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationBridged Bicyclo Compounds, HeterocyclicLeukemia, Myeloid, AcuteSulfonamidesNucleophosminHumansMaleFemaleMiddle AgedAdultAgedRetrospective StudiesYoung AdultAntineoplastic Combined Chemotherapy ProtocolsRecurrence

Stichwörter der Autor:innen

AzacitidineDecitabineHematopoietic transplantVenetoclax

Substanzen

venetoclaxBridged Bicyclo Compounds, HeterocyclicSulfonamidesNucleophosminNPM1 protein, human

Autor:innen und Institutionen

  • Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL.
  • University of South Florida/Morsani School of Medicine, Tampa, FL.
  • Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address: jeffrey.lancet@moffitt.org.

Förderung

  • Moffitt Cancer Center

Zitieren

APA

Ionescu, F., David, J. C., Ravichandran, A., Sallman, D. A., Sweet, K., Komrokji, R. S., Chan, O., Kuykendall, A., Padron, E., Faramand, R., Bejanyan, N., Khimani, F., Elmariah, H., Pidala, J., Mishra, A., Perez, L., Nishihori, T., & Lancet, J. E. (2024). Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant. Clinical Lymphoma Myeloma and Leukemia, 24(6), 400-406. https://doi.org/10.1016/j.clml.2024.02.005

Vancouver

Ionescu F, David JC, Ravichandran A, Sallman DA, Sweet K, Komrokji RS, et al. Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant. Clinical Lymphoma Myeloma and Leukemia. 2024;24(6):400-406. doi:10.1016/j.clml.2024.02.005

BibTeX
@article{Ionescu2024,
  author = {Ionescu, Filip and David, Jerel C and Ravichandran, Apoorva and Sallman, David A and Sweet, Kendra and Komrokji, Rami S and Chan, Onyee and Kuykendall, Andrew and Padron, Eric and Faramand, Rawan and Bejanyan, Nelli and Khimani, Farhad and Elmariah, Hany and Pidala, Joseph and Mishra, Asmita and Perez, Lia and Nishihori, Taiga and Lancet, Jeffrey E},
  title = {Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2024},
  volume = {24},
  number = {6},
  pages = {400--406},
  doi = {10.1016/j.clml.2024.02.005}
}
Kostenlos starten →